- Home
- ANTX vs MDBH Comparison
ANTX vs MDBH Comparison
Compare ANTX & MDBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTX
- MDBH
- Stock Information
- Founded
- ANTX 2017
- MDBH 1997
- Country
- ANTX United States
- MDBH United States
- Employees
- ANTX N/A
- MDBH N/A
- Industry
- ANTX Biotechnology: Pharmaceutical Preparations
- MDBH
- Sector
- ANTX Health Care
- MDBH
- Exchange
- ANTX Nasdaq
- MDBH Nasdaq
- Market Cap
- ANTX 37.3M
- MDBH 42.3M
- IPO Year
- ANTX 2022
- MDBH 2023
- Fundamental
- Price
- ANTX $1.20
- MDBH $4.40
- Analyst Decision
- ANTX Buy
- MDBH
- Analyst Count
- ANTX 4
- MDBH 0
- Target Price
- ANTX $2.00
- MDBH N/A
- AVG Volume (30 Days)
- ANTX 133.7K
- MDBH 3.8K
- Earning Date
- ANTX 05-16-2025
- MDBH 05-16-2025
- Dividend Yield
- ANTX N/A
- MDBH N/A
- EPS Growth
- ANTX N/A
- MDBH N/A
- EPS
- ANTX N/A
- MDBH 0.81
- Revenue
- ANTX N/A
- MDBH $2,085,644.00
- Revenue This Year
- ANTX N/A
- MDBH N/A
- Revenue Next Year
- ANTX N/A
- MDBH N/A
- P/E Ratio
- ANTX N/A
- MDBH $5.45
- Revenue Growth
- ANTX N/A
- MDBH N/A
- 52 Week Low
- ANTX $0.87
- MDBH $3.80
- 52 Week High
- ANTX $3.07
- MDBH $12.00
- Technical
- Relative Strength Index (RSI)
- ANTX 43.48
- MDBH 36.34
- Support Level
- ANTX $1.05
- MDBH $4.31
- Resistance Level
- ANTX $1.29
- MDBH $4.49
- Average True Range (ATR)
- ANTX 0.07
- MDBH 0.10
- MACD
- ANTX -0.00
- MDBH 0.07
- Stochastic Oscillator
- ANTX 54.55
- MDBH 61.54
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.
About MDBH MDB Capital Holdings LLC common
MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.